• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Novo Nordisk A/S (NVO)

    -NYSE
    47.75 Up 0.22(0.46%) Feb 27, 4:04PM EST
    Add to Portfolio
    Prev Close:47.53
    Open:47.40
    Bid:47.40 x 900
    Ask:47.58 x 4900
    1y Target Est:58.52
    Beta:0.75
    Next Earnings Date:N/A
    Day's Range:47.35 - 48.03
    52wk Range:41.72 - 49.11
    Volume:1,046,418
    Avg Vol (3m):1,362,160
    Market Cap:124.14B
    P/E (ttm):31.58
    EPS (ttm):1.51
    Div & Yield:0.76 (1.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVOUp 0.46%124.14B
    LLYUp 0.20%74.42B
    PFEDown 0.78%216.24B
    SNYDown 0.02%128.58B

    Key Statistics

    Forward P/E (1 yr):25.40
    P/S (ttm):9.27
    Ex-Dividend Date:19-Mar-15

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback